Speece Thorson Capital Group Inc. Acquires 39,352 Shares of Henry Schein, Inc. (NASDAQ:HSIC)

Speece Thorson Capital Group Inc. raised its holdings in Henry Schein, Inc. (NASDAQ:HSIC) by 20.0% during the 3rd quarter, according to its most recent filing with the Securities and Exchange Commission. The fund owned 235,967 shares of the company’s stock after buying an additional 39,352 shares during the period. Henry Schein accounts for about 3.2% of Speece Thorson Capital Group Inc.’s portfolio, making the stock its 9th largest holding. Speece Thorson Capital Group Inc.’s holdings in Henry Schein were worth $17,202,000 as of its most recent SEC filing.

Other hedge funds and other institutional investors have also recently added to or reduced their stakes in the company. Cromwell Holdings LLC increased its stake in shares of Henry Schein by 93.4% during the 3rd quarter. Cromwell Holdings LLC now owns 352 shares of the company’s stock worth $26,000 after purchasing an additional 170 shares during the last quarter. Covestor Ltd grew its stake in Henry Schein by 12.8% in the 1st quarter. Covestor Ltd now owns 1,511 shares of the company’s stock valued at $114,000 after buying an additional 171 shares during the last quarter. Simplify Asset Management Inc. grew its stake in Henry Schein by 5.0% in the 2nd quarter. Simplify Asset Management Inc. now owns 3,695 shares of the company’s stock valued at $237,000 after buying an additional 175 shares during the last quarter. Sequoia Financial Advisors LLC grew its stake in Henry Schein by 3.2% in the 2nd quarter. Sequoia Financial Advisors LLC now owns 5,680 shares of the company’s stock valued at $364,000 after buying an additional 176 shares during the last quarter. Finally, Studio Investment Management LLC grew its stake in Henry Schein by 4.7% in the 2nd quarter. Studio Investment Management LLC now owns 4,502 shares of the company’s stock valued at $289,000 after buying an additional 204 shares during the last quarter. 96.62% of the stock is currently owned by institutional investors and hedge funds.

Insider Buying and Selling at Henry Schein

In other Henry Schein news, SVP Lorelei Mcglynn sold 21,035 shares of the firm’s stock in a transaction on Friday, September 6th. The shares were sold at an average price of $69.30, for a total value of $1,457,725.50. Following the transaction, the senior vice president now directly owns 71,833 shares of the company’s stock, valued at approximately $4,978,026.90. This trade represents a 0.00 % decrease in their ownership of the stock. The transaction was disclosed in a filing with the Securities & Exchange Commission, which is accessible through this hyperlink. Insiders own 1.14% of the company’s stock.

Analysts Set New Price Targets

A number of analysts have issued reports on HSIC shares. Baird R W raised shares of Henry Schein from a “hold” rating to a “strong-buy” rating in a report on Monday, July 22nd. StockNews.com raised shares of Henry Schein from a “sell” rating to a “hold” rating in a report on Thursday, November 7th. Barrington Research reaffirmed an “outperform” rating and set a $82.00 price target on shares of Henry Schein in a report on Wednesday, November 6th. Evercore ISI upped their price objective on shares of Henry Schein from $70.00 to $74.00 and gave the stock an “in-line” rating in a research report on Tuesday, October 8th. Finally, Robert W. Baird lowered their price objective on shares of Henry Schein from $92.00 to $82.00 and set an “outperform” rating for the company in a research report on Wednesday, August 7th. One analyst has rated the stock with a sell rating, six have assigned a hold rating, five have given a buy rating and one has issued a strong buy rating to the stock. Based on data from MarketBeat, the stock has an average rating of “Hold” and a consensus price target of $77.50.

Henry Schein Stock Down 0.7 %

NASDAQ HSIC traded down $0.46 on Wednesday, hitting $67.00. 63,022 shares of the company were exchanged, compared to its average volume of 1,348,283. The company has a market cap of $8.35 billion, a PE ratio of 27.76, a PEG ratio of 1.96 and a beta of 0.87. Henry Schein, Inc. has a 12 month low of $63.67 and a 12 month high of $82.63. The stock has a fifty day moving average of $70.40 and a 200-day moving average of $69.63. The company has a current ratio of 1.42, a quick ratio of 0.82 and a debt-to-equity ratio of 0.46.

Henry Schein (NASDAQ:HSIC) last issued its earnings results on Tuesday, November 5th. The company reported $1.22 earnings per share (EPS) for the quarter, topping the consensus estimate of $1.17 by $0.05. The business had revenue of $3.17 billion for the quarter, compared to analyst estimates of $3.24 billion. Henry Schein had a net margin of 2.51% and a return on equity of 12.90%. Henry Schein’s revenue was up .4% on a year-over-year basis. During the same period in the prior year, the firm earned $1.32 earnings per share. As a group, analysts forecast that Henry Schein, Inc. will post 4.78 earnings per share for the current year.

Henry Schein Company Profile

Henry Schein, Inc provides health care products and services to dental practitioners, laboratories, physician practices, and ambulatory surgery centers, government, institutional health care clinics, and other alternate care clinics worldwide. It operates through two segments, Health Care Distribution, and Technology and Value-Added Services.